ORPEA

Earnings Release • Oct 3, 2024

PRESS RELEASE 2024 half-year results

Puteaux, October 3rd , 2024 – 6:30 pm CEST

2024 half-year results Outlook reaffirmed, acceleration of disposals

A renewed framework and solid fundamentals

Improving the fundamentals of our core activities to support future performance

• The Group's transformation draws on its people, the quality of care it provides and the optimisation of its processes. These three focus areas are the levers of tomorrow's operational and financial performance. We are already seeing progress (satisfaction rate up to 92.4%, stabilisation of teams with staff turnover down -3 points and absenteeism down -1.4 points since 2022, a sharp -21% decrease in the frequency rate of work-related accidents with lost time in six months, etc.), and gradual effects on operating indicators.
• emeis has reaffirmed its ambition to become a mission-led company in 2025.

Growth in all core activities and in all geographical areas

• Solid growth of +9.2%, including +8.9% on an organic basis, reflecting the initial payoffs from the measures taken in the last 18 months.
• The occupancy rate is up in all geographical areas and all core activities (by +2.6 points on average).
• Positive price effect also observed across all the Group's markets (of +5.5% on average).
• The solid level of business since the start of the second half of the year confirms this favourable trend.

EBITDAR stable due to stimulus measures in France

• Discrepancy between the immediate effects of stimulus measures on expenses and the more gradual effects on revenue.
• Residual impacts of the recent inflationary episode.

A gradually recovering balance sheet

• Net debt down to €4,425 million at end-June 2024, i.e., down -€217 million over six months and down almost -€4.8 billion over 12 months.
• Financial expenses down -24%, reflecting the positive impact of the financial restructuring.
• Progress on the property disposal programme: €452 million since mid-2022, including €159 million since January.
• Free cash flow improved by +€111 million, reflecting some of the effects of the precautionary measures taken in recent months, but remained negative at -€178 million.

Confirmation of EBITDAR target and acceleration of expected disposals

• emeis confirms the outlook announced on 26 July when it published its first-half revenue figures.
• 2024 EBITDAR is expected to increase by 0% to +5%, i.e., between €700 million and €730 million.
• Stepped up ambitions for disposals of real estate and operating assets to reach €1.5 billion between mid-2022 and the end of 2025 with the aim of continuing to reduce the Group's debt.

Key figures1		H1 2023	H1 2024	Change	o/w organic
in €m
Revenue		2,539	2,772	+9.2%	+8.9%
	o/w nursing homes	1,580	1,763	+11.6%
	o/w clinics	837	880	+5.1%
Personnel costs		(1,697)	(1,896)	+11.7%
Other expenses		(506)	(537)	+6.0%
EBITDAR		336	339	+0.8%
EBITDAR margin		13.2%	12.2%
EBITDA		321	316	-1.6%
EBITDA margin		12.6%	11.4%
Net financial expense		(231)	(176)	-23.7%
Attributable net profit/(loss)		(371)	(257)	+€144m
Per share (diluted), in €		€(5.74)	€(1.71)	NM
Free cash flow2		(289)	(178)	+€111m

¹ Pre-IFRS-16 key figures are provided in Appendix 1 of this press release, page 10.

² Net cash flow before financing (see Appendix 3).

Laurent Guillot, Chief Executive Officer, said: "The performance delivered by emeis in the first half of 2024 attests to good momentum in all our activities and geographical areas. Our non-financial indicators, particularly those relating to the occupational safety of our teams and quality of care, continue to improve, demonstrating that the transformation initiated in 2022 is now bearing fruit: the number of workplace accidents has been halved compared with 2021, staff turnover is down, and satisfaction indicators for our patients, residents and their loved ones are also improving significantly. These fundamentals provide a solid foundation for the recovery that is now underway.

In the first half of the year, revenue rose by almost 9%, which is above comparable figures for the sector. This performance was driven by a 2.6-point improvement in the average occupancy rate and a 5.5% positive price effect across all our activities and geographical areas. Although we must remain vigilant and cautious, this upward trend has been evident since the start of the third quarter, proof of the favourable operating momentum that is taking shape.

The stability of the Group's EBITDAR over the first half of 2024 reflects our investment in the emeis teams in necessary response to the recent gradual increase in occupancy rates. In the short term, however, the effort made by emeis in France is being offset by all the other geographies where EBITDAR margins are on the rise.

We now need to extend and accelerate today's recovery momentum, and build on our Group's sustainable strengths for the years to come. To do this, we are capitalizing on a more robust balance sheet, while preparing to transform emeis into a mission-led company next year, based on our mission statement: 'Together, let's stand as a strength for the vulnerable among us'."

Press contacts

Isabelle HERRIER NAUFLE Director of Press Relations & e Reputation +33 7 70 29 53 74 isabelle.herrier@emeis.com

IMAGE 7 Charlotte LE BARBIER // Laurence HEILBRONN

+33 6 78 37 27 60 // +33 6 89 87 61 37 clebarbier@image7.fr // lheilbronn@image7.fr

Investor Relations

Samuel Henry Diesbach samuel.henry-diesbach@emeis.com

Toll-free number for shareholders (from France only) 0 805 480 480

NEWCAP Dusan Oresansky +33 1 44 71 94 94 emeis@newcap.eu

About emeis

With nearly 78,000 experts and professionals in healthcare, care, and supporting the most vulnerable among us, emeis operates in around 20 countries with five core activities: psychiatric hospitals, post-acute and rehabilitation hospitals, nursing homes, home care services, and assisted-living facilities.

Every year, emeis welcomes 283,000 residents, patients, and other beneficiaries. emeis is committed and is taking action to rise to a major challenge facing our society, i.e., the increase in the number of people placed in vulnerable positions as a result of accidents or old age, and the rising number of cases of mental illness.

emeis is 50.2% owned by Caisse des Dépôts, CNP Assurances, MAIF, and MACSF Épargne Retraite. It is listed on the Euronext Paris stock exchange (ISIN: FR001400NLM4) and is a member of the SBF 120 and CAC Mid 60 indices. Website: www.emeis.com/en

www.emeis.com/en Press release – Half-year results – 3 October 2024 Page 2/16

A renewed framework and solid fundamentals

Supported by renewed governance and a strengthened Management team, emeis, embodying the new identity unveiled during the first half of the year to accelerate transformation and shape a sustainable and profitable business model, is laying solid foundations for its medium-term development.

Thanks to our many strengths enhanced by the refoundation plan, the commitment of our teams around a recognised medical project and a new corporate plan hinging on a mission statement endorsed by the shareholders, "Together, let's stand as a strength for the vulnerable among us", the Group is already seeing the first non-financial effects of the upward trend in the Group's financial indicators (satisfaction rate up +2.3 points versus 2022 to 92.4%, a -3-point reduction in staff turnover versus 2022, a -21% reduction in workplace accidents in a six-month period).

Increase in revenue (+9%): improved occupancy rate and favourable price effect

In the first half of 2024, the emeisGroup's consolidated revenue rose significantly, with growth of +8.9% on an organic basis, and +9.2% based on the current scope of consolidation.

The improvement reflects the increase in occupancy rates and favourable price increases across all the Group's core activities and geographical areas.

Overall, the Group's average occupancy rate rose by +2.6 points to 85.3%, lifted by a marked upturn in Northern Europe (+4.2 points) and Southern Europe and Latin America (+4.5 points), which is an encouraging sign for the Group's future prospects.

This recovery trend is backed up by the initial business indicators observed since the start of the second half of the year, with the rise in occupancy rates seen in June still continuing, particularly in the French market.

EBITDAR margin remains temporarily under pressure

EBITDAR came to €339 million for the period, up +0.8% on first-half 2023, representing a margin of 12.2%.

Operating profitability continued to be temporarily affected by necessary measures implemented to gradually normalise the Group's occupancy rates, with the aim of improving quality of care and support. These measures have an immediate impact on personnel costs and a gradual effect on revenue. The corresponding time lag is temporarily weighing on EBITDAR margins.

For other operating expenses, the recent inflationary episode also impacted the Group's margin, while the occupancy rate in nursing homes in France remained below its normal level.

1- Key income statement items for the first half of 2024

In publishing its 2024 half-year results, the Group refers to financial indicators taken from its consolidated financial statements, as well as to alternative performance measures, which are presented in detail in the appendices to this press release. Definitions and calculation methods for these indicators are presented in the appendices to this press release.

(in millions of euros)	30 June 2023	30 June 2024
REVENUE	2,539	2,772
Personnel costs	(1,697)	(1,896)
Other expenses	(506)	(537)
EBITDAR	336	339
EBITDAR %	13.2%	12.2%
EBITDA	321	316
Depreciation, amortisation and charges to provisions	(334)	(330)
RECURRING OPERATING PROFIT/(LOSS)	(13)	(14)
Other non-recurring operating income and expense	(85)	(12)
OPERATING PROFIT	(98)	(25)
Net financial expense	(231)	(176)
PROFIT BEFORE TAX	(329)	(202)
Income tax expense	(39)	(33)
Share in profit/(loss) of associates and joint ventures	1	(24)
Attributable to non-controlling interests	(4)	1
NET PROFIT ATTRIBUTABLE TO SHAREHOLDERS	(371)	(257)
Diluted earnings/(loss) per share, in €	(5.74)(2)	(1.71)(1)

(1) The first-half 2024 figures have been restated to take account of the impact of the reverse stock split in March 2024, in accordance with IAS 23.

(2) The first-half 2023 figures have not been restated for the reverse stock split in March 2024, since this was after the reporting date.

Revenue for the entire first half of 2024 came to €2,772 million, a +9.2% increase on first-half 2023 including +8.9% organic growth.

Revenue grew sharply in the first half of 2024, driven by positive price and care allowance effects (for +5.5% on average at Group level) and by a marked recovery in occupancy rates, internationally in particular, and the opening of new facilities. The rise in occupancy rates and the favourable contribution of price increases was observed across all geographical areas and all core activities.

Revenue for nursing homes was up +11.6% to €1,763 million. For clinics, it increased by +5.1% to €880 million.

(in million euros)	H1 2023 Revenue	H1 2024 Revenue	Growth (%)	Organic Growth (%)*
France	1,137	1,183	+4,0%	+4,8%
Northern Europe	695	796	+14,6%	+11,9%
Central Europe	425	472	+11,1%	+11,3%
Southern Europe & Latam	188	211	+11,8%	+13,2%
Other geographies	94	110	+16,7%	+17,6%
TOTAL	2,539	2,772	+9,2%	+8,9%

The average occupancy rate rose by +2.6 points between the two periods, to 85.3% for the first half of 2024.

• The rise in the occupancy rate was driven in particular by Southern Europe and Latam (Spain, Italy, Portugal and Latin America) and Northern Europe (Germany, Netherlands, Belgium and Luxembourg).
• In France, the occupancy rate was slightly up on first-half 2023, at 85.8%, with a level above 92% for clinics and a slight increase for nursing homes (83.1% on average over the first half of 2024, i.e., up +0.1 point) which began mainly at the end of the period.

Average occupancy rate	H1 2023	H1 2024	Var.
France	85,3 %	85,8 %	+0,4 bps
Northern Europe	78,4 %	82,6 %	+4,2 bps
Central Europe	86,7 %	89,8 %	+3,1 bps
Southern Europe & Latam	83,3 %	87,8 %	+4,5 bps
Other geographies	n.m.	n.m.	n.a.
Total	82,7 %	85,3 %	+2,6 bps

The occupancy rate for nursing homes rose by +3 points to 84.5%, and was up +0.9 points for clinics to 88%.

EBITDAR came to €339 million in the first half of 2024, up +0.8%, reflecting a margin of 12.2%. As the increase in EBITDAR from operations outside France (+€51 million) was accompanied by a reduction of the same order of magnitude in EBITDAR from operations in France, EBITDAR remained stable overall between the first half of 2023 and the first half of 2024.

(in million euros)	H1 2023 EBITDAR	H1 2024 EBITDAR	H1 2023 EBITDAR %	H1 2024 EBITDAR %	Var. vs H1 2023
France	169	121	14,8 %	10,2 %	(460) bps
Northern Europe	109	118	15,7 %	14,8 %	(95) bps
Central Europe	70	88	16,5 %	18,7 %	+216 bps
Southern Europe & Latam	17	24	8,9 %	11,3 %	+239 bps
Other geographies	12	16	ns	ns	ns
Group headquarters	(42)	(28)	ns	ns	ns
TOTAL	336	339	13,2 %	12,2 %	(101) bps

The stable EBITDAR performance, despite an increase in revenue, mainly reflects a time lag between the immediate effect on expenses of operational recovery measures and their more gradual impact on revenue.

Personnel costs thus rose by +11.7% in the first half, reflecting the Group's commitment to continue improving the quality of its services and reduce staff turnover. The increase in personnel costs reflects salary increases and growth in the workforce over the period. Other operating expenses for our facilities (catering, care, energy, etc.) rose by +6.0%, mainly due to the residual effects of inflation.

EBITDA amounted to €316 million, representing a margin of 11.4%. Pre-IFRS 16 EBITDA amounted to €92 million, giving a margin of 3.3%, down -0.7 point on the same period last year.

Net financial expense fell by -24% to -€176 million, mainly reflecting the positive impact of the financial restructuring carried out over the last 12 months.

Non-recurring expenses were also down significantly in the six months ended 30 June 2024 compared with the first half of 2023, representing -€12 million for the period compared with -€85 million a year ago. The decrease mainly reflects the reduction in fees in connection with the restructuring achieved in 2023.

As a result, emeis again reported an attributable net loss for the first half, in an amount of -€257 million, but with a €114 million improvement compared with the first half of 2023. On a fully diluted basis, the loss per share came out at -€1.71 versus -€5.74 in first-half 2023.

2- Estimated value of the real estate portfolio

The estimated value of the real estate portfolio was €6.3 billion, compared with €6.5 billion at the end of 2022, based on the current scope of consolidation. At end-2023, independent valuers³ appraised a total of 414 facilities located mainly in France, representing assets worth €5.3 billion.

The portfolio is appraised at the end of each financial year. At the end of December 2023, the average yield on appraised assets was approximately 6% (excluding duties).

Since the end of 2021, the value of the portfolio has been adjusted downwards by -21% on a comparable scope basis, reflecting the impact of the rise in interest rates over the period, and the corresponding increase in real estate investors' yield requirements.

3 JLL, C&W and CBRE.

3- Cash flow for the first half of 2024

(in million euros)	30/06/2023	30/06/2024
EBITDA pre IFRS 16	102	92
Maintenance & IT Capex	(53)	(60)
Other operating cash flows (incl.change in working capital)	(62)	(44)
Net Operating Cash Flow	(13)	(12)
Real Estate Development capex	(192)	(91)
Non recurring items	(59)	(99)
Asset portfolio management	36	143
Net financial expenses	(60)	(119)
Free Cash Flow	(289)	(178)
Change in equity - cash	-	390
Change in perimeter	(12)	(7)
Chg. in IFRS adjustments	(201)	12
Chg. in net financial debt	(502)	217

Net free cash flow before financing was -€178 million, an improvement of +€111 million compared with the first half of 2023, reflecting the combination of the following factors:

• The significant reduction in development capex (mainly real estate), which came to -€91 million (versus -€192 million in the first half of 2023). The -€102 million decrease compared with the first half of 2023 reflects the implementation during the period of precautionary measures as part of a project review (postponements, adjustments and cancellations) in order to preserve the Group's liquidity and focus development on the most favourable transactions.
• €143 million in proceeds from real estate disposals in the first half (mainly in the Netherlands, Portugal and Ireland). The latest disposals bring the total proceeds from real estate disposals received since mid-2022 to €451 million. Disposals in the coming six-month periods may also include operating assets.
• The cost of debt in the cash flow statement rose by +€59 million to €119 million, returning to a normal level of outflows, even though a portion of borrowing costs was frozen until the first half of 2023 during the restructuring process.
• -€99 million in non-recurring items, including expenses related to the management of the crisis experienced by the Group. The vast majority of these items relate to 2023 expenses paid in the first half of 2024 and therefore correspond to outflows in respect of expenses for which provisions have already been made.

There was also a €390 million cash contribution, corresponding to the final capital increase planned as part of the Group's financial restructuring, carried out in February 2024. The equivalent of 29.3 million new shares (post reverse stock split) were created on this occasion.

As a result, the Group's net debt⁴ stood at €4,425 million, down -€217 million versus 31 December 2023 (€4,642 million).

⁴ Excl IFRS 16 debt

4- Main consolidated balance sheet, debt and liquidity indicators

(in million euros)	31/12/2023	30/06/2024
Net tangible assets (*)	4,775	4,752
Right-of-use assets (IFRS 16)	3,084	3,080
Net intangible assets	1,513	1,470
Goodwill	1,386	1,392
Total equity	1,888	1,925
Gross financial debt (excl. IFRS 16)	5,287	5,078
Short-term financial debt	746	665
Cash and cash equivalents	645	653
Financial Net debt (excl. Lease liabilities IFRS 16)	4,642	4,425
Lease liabilities IFRS 16	3,874	3,871
Short-term lease liabilities IFRS 16	560	524

(*) including assets in progress: €406m at year-end 2023 and €480m at June 2024

Net debt (excluding IFRS 16 lease liabilities) at 30 June 2024 stood at €4,425 million, compared with €4,642 million at end-2023. The reduction in net debt over six months is mainly due to the third capital increase (€390 million), provided under the financial restructuring plan (completed on 15 February 2024), while the Group's free cash flow, although still negative, improved by a significant €111 million compared with the first half of 2023.

As a reminder, the Group's net debt at the end of 2022 was €8.8 billion.

59% of gross debt at end-June 2024 corresponded to secured debt with the Group's main banking partners (G6), maturing mainly in October 2027. In addition, mortgage, leasing debt and other secured debt accounts for 34% of the total.

Cash and cash equivalents at the end of June 2024 amounted to €653 million, broadly comparable to the level reported at the end of 2023, and €1,053 million including a €400 million "new money" additional credit facility, which was undrawn at that date. On 1 October 2024, drawdown requests were made on this facility in accordance with the applicable documentation. The funds are expected to be made available by the lenders on 7 October 2024. The schedule of lease maturities, published in the appendix to this press release, shows €456 million maturing in the second half of 2024.

In the first half, the average cost of gross debt was 5.44%⁵ , up from 4.71% in the first half of 2023. The increase in the average cost of debt is mainly due to the fact that the debt was converted into capital, with a lower margin than the Group average.

⁵ before hedging instruments

5- Cumulative disposals: €452 million since mid-2022, and €1.5 billion expected by the end of 2025 emeis continued to carry out a large volume of real estate disposals in an albeit tight investment market in which investors are still taking a wait-and-see approach. The drop in interest rates following the easing of monetary policy could nevertheless contribute to a gradual recovery in investment volumes.

emeis has managed to complete almost €452 million in property disposals⁶ since mid-2022, including €159 million in the first half. In addition, at the end of June, €106 million in further disposals were still subject to binding offers which will be finalised over the next 18 months.

In total, the volume invested by the Group since 2022 represents almost 30% of the Continental European healthcare real estate investment market, which underlines not only the Group's expertise in this area, but also the quality of its portfolio.

In order to continue reducing its debt and fulfil its bank covenants⁷ , the emeis Group will be accelerating its disposals, and now aims to dispose of €1.5 billion in real estate⁸ and operational9 assets between June 2022 and December 2025.

6- 2024 outlook reaffirmed

The trends observed since the start of the second half, particularly regarding the occupancy rate of the Group's residences, confirm that the Group's operating markets are engaged in a recovery which, although more gradual than expected in France, is on an encouraging trajectory in all markets.

The Group is therefore reaffirming the outlook it issued at the end of July 2024, anticipating EBITDAR for 2024 of between €700 million and €730 million. This outlook was communicated on 26 July in the half-year revenue press release, taking into account a more gradual than expected operational recovery in France. On this basis, pre-IFRS 16 2024 EBITDA would come to around €210 million in 2024.

⁹ Amount expressed in equity value.

⁶ Mainly sale and leaseback transactions.

⁷ Available liquidity in excess of €300 million, tested quarterly, and net debt/EBITDA ratio below 9x, tested half-yearly from June 2025 on €203m outstanding debt.

⁸ Amount expressed in net selling value before repayment of associated debt.

APPENDICES

A web conference is scheduled to be held by Laurent Guillot (Chief Executive Officer) and Jean-Marc Boursier (Chief Financial Officer) at 10:00 a.m. (CEST) on 4 October. The conference will be accompanied by a presentation and a recording of the web conference will be made available on the Company's website.

2024 HALF-YEAR CONSOLIDATED FINANCIAL STATEMENTS

emeis S.A. publishes its consolidated results for the six months ended 30 June 2024, which were approved by the Board of Directors on 3 October 2024. 10

1. Consolidated income statement (pre- and post-IFRS 16 reconciliation)

	30/06/2023 30/06/2024
(in million euros)	Pre IFRS 16	IFRS 16 impact	Post IFRS 16	Pre IFRS 16	IFRS 16 impact	Post IFRS 16
REVENUE	2 539	-	2 539	2 772	-	2 772
Personnel costs	(1 697)	-	(1 697)	(1 896)	-	(1 896)
As a % of revenue	-66,8%	n.a.	-66,8%	-68,4%	n.a.	-68,4%
Other costs	(511)	5	(506)	(542)	5	(537)
As a % of revenue	-20,1%	n.a.	-19,9%	-19,5%	n.a.	-19,4%
EBITDAR	330	5	336	334	5	339
% EBITDAR	13,0%	n.a.	13,2%	12,0%	n.a.	12,2%
External rental costs	(229)	214	(14)	(242)	220	(22)
EBITDA	102	219	321	92	224	316
% EBITDA	4,0%	n.a.	12,6%	3,3%	n.a.	11,4%
Depreciation, amortisation and charges to provisions	(170)	(164)	(334)	(171)	(159)	(330)
RECURRING OPERATING PROFIT	(69)	56	(13)	(79)	65	(14)
As a % of revenue	-2,7%	n.a.	-0,5%	-2,9%	n.a.	-0,5%
Net financial result	(173)	(58)	(231)	(113)	(63)	(176)
Other non-recurring operating income and expenses	(60)	(26)	(85)	(39)	28	(12)
Profit / (loss) before tax	(301)	(28)	(329)	(232)	30	(202)
Income tax	(45)	6	(39)	(30)	(3)	(33)
Share in profit / (loss) of associates and JV	1	-	1	(24)	-	(24)
NET PROFIT	(345)	(22)	(367)	(285)	27	(258)
Profit / (loss) attributable to non-controlling interest	(4)	0	(4)	1	0	1
NET PROFIT ATTRIBUTABLE TO SHAREHOLDERS	(349)	(22)	(371)	(285)	27	(257)

¹⁰ The half-year financial statements have been reviewed by the Statutory Auditors, whose corresponding report is currently being prepared for issue.

2. Consolidated balance sheet

Consolidated balance sheet (in million euros)	31/12/2023	30/06/2024
Non-current assets	11,538	11,422
Goodwill	1,386	1,392
Intangible assets, net	1,513	1,470
Property, plant and equipment, net	4,369	4,272
Assets in progress	406	480
Right of use assets	3,084	3,080
Non-current financial assets	139	137
Deferred tax assets	641	592
Current assets	1,837	2,048
Cash and cash equivalents	645	653
Assets held for sale	533	371
TOTAL ASSETS	13,908	13,841

TOTAL LIABILITIES	13,908	13,841
Liabilities held for sale	76	80
Other payables, accruals and prepayments	651	876
Current tax liabilities	57	48
Tax and payroll liabilities	523	576
Trade payables	502	343
short term provisions	7	8
Short-term lease liabilities	560	524
Short-term financial debt	,746	665
Current financial liabilities	3,045	3,038
Deferred tax liabilities	663	657
Provisions for pensions and other employee benefit obligations	73	72
Long term provisions	307	310
Long-term lease liabilities	3,314	3,347
Long-term financial debt	4,541	4,413
Non-current financial liabilities	8,899	8,799
Total consolidated equity	1,888	1,925
Equity attributable to ORPEA's shareholders	1,887	1,923

3. Simplified statement of cash flows

(in million euros)	30/06/2023	30/06/2024
EBITDA pre IFRS 16	102	92
Maintenance & IT Capex	(53)	(60)
Other operating cash flows (incl.change in working capital)	(62)	(44)
Net Operating Cash Flow	(13)	(12)
Real Estate Development capex	(192)	(91)
Non recurring items	(59)	(99)
Asset portfolio management	36	143
Net financial expenses	(60)	(119)
Free Cash Flow	(289)	(178)
Change in equity - cash	-	390
Change in perimeter	(12)	(7)
Chg. in IFRS adjustments	(201)	12
Chg. in net financial debt	(502)	217
TOTAL NET FINANCIAL DEBT	9 260	4 425

CONSOLIDATED STATEMENT OF CASH FLOWS (€m)	H1 2023	H1 2024
Consolidated net income	(367)	(258)
Elimination of non-cash income and expenses relating to activities (*)	194	132
IFRS16 impact (amortization and impairment of assets)	198	177
Financial income and expenses, excluding financial expenses on lease liabilities	185	105
Financial expenses on lease liabilities	58	64
Cash flows from operations generated by consolidated companies	268	220
Change in working capital related to operations	(76)	(55)
Net cash generated from operating activities [1]	192	165
Tangible and intangible operating investments	(53)	(60)
Property development investments	(158)	(91)
Real estate disposals	13	159
Other acquisitions and disposals	(15)	(10)
Cash flow from investing and development activities [2]	(214)	(1)
Capital increases (monetary impact). Net proceeds	-	390
Net cash inflows/(outflows) related to bridging loans and bank overdrafts	200	41
Proceeds from new finance leases	(166)	(181)
Repayments of lease liabilities	(58)	(64)
Repayments of other borrowings	(168)	(157)
Repayments under finance leases	(70)	(63)
Net financial income/expense and other changes	(56)	(121)
Net cash from financing activities [3]	(318)	(155)
CHANGE IN CASH AND CASH EQUIVALENTS [1]+[2]+[3]	(339)	8

4. Calculation methods for EBITDAR and pre-IFRS 16 EBITDA

(in million euros)	30/06/2023	30/06/2024
OPERATING PROFIT / (LOSS)	(98)	(25)
Neutralisation of non-recurring operating income and expenses	85	12
RECURRING OPERATING PROFIT / (LOSS)	(13)	(14)
Neutralisation of Depreciation, amortisation and charges to provisions	334	330
EBITDAR	321	316
Neutralisation of rental charges	14	22
EBITDAR	336	339
IFRS 16 - Restatement of external leases	(219)	(224)
IFRS 16 - Restatement of operating expenses	(14)	(22)
EBITDA PRE-IFRS 16	102	92

5. Information about pre-IFRS 16 alternative performance measures

Income statement aggregates IFRS 16	H1 2023	H1 2024
EBITDA pre IFRS16	102	92
Rental IFRS 16	219	224
EBITDA margin pre IFRS 16	4,0%	3,3%
Recurring operating profit pre IFRS 16	(69)	(79)
Recurring operating margin pre IFRS 16	-2,7%	-2,9%
Cash Flow pre IFRS 16	H1 2023	H1 2024
Operating cash flow [pre IFRS 16]	(27)	(60)
Net Investment cash flows	(214)	(1)
Net financing flows [pre IFRS 16]	(98)	69
Change in cash	(339)	8

Reminder of cash-flow "GAAPS"	H1 2023	H1 2024
Cash flow from operations (after tax)	268	220
Change in working capital	(76)	(55)
Net cash generated from operating activities	192	165
Cash flow from investing and development	(214)	(1)
Net cash from financing activities	(318)	(155)
Change in cash	(339)	8

6. Reconciliation of cash flows

(in million euros)	30/06/2023	30/06/2024
Net cash flow from operations	192	165
Neutralisation IFRS 16 P&L impact	(219)	(224)
Net cash flow from operations Pre IFRS 16	(27)	(60)
Change in WCR - Reclassification of cash flows from investing activities	13	8
Reclassification of financial items	4	-
Reclassification of non-current items	59	99
Additional reimbursement of IFRS 16 debt	(9)	(0)
Maintenance and IT investments	(53)	(60)
NET CURRENT OPERATING CASH-FLOW	(13)	(12)

(in million euros)	30/06/2023	30/06/2024
Net cash flow from operations	(13)	(12)
Neutralisation IFRS 16 P&L impact	(192)	(91)
Asset portefolio Management	(59)	(99)
Non-current items	36	143
Financial result	(60)	(119)
NET CASH-FLOW BEFORE FINANCING	(289)	(178)

7. Maturity schedule of gross debt at end-June 2024

8. Share capital

	30/06/2024
	Number of shares	Diluted
Average Number of shares issued	150 775 069	150 775 069
Treasury shares	-38 124	-38 124
Other shares		1 349 312
Shares related to the exercise of options (BSA)		2 333 167
Weighted average number of shares	150 736 945	154 419 424
11

Number of ordinary shares at end-June 2024: 159,191,703 Number of shares (fully diluted) at end-June: 162,759,998

Breakdown of the share capital at end-June 2024

¹¹ The first-half 2024 figures have been restated to take into account the impact of the reverse stock split in March 2024, in accordance with IAS 33.

DEFINITIONS

Organic growth	The organic growth of the Group's revenue includes: 1. The year-on-year change in the revenue of existing facilities as a result of changes in their occupancy rates and per diem rates; 2. The year-on-year change in the revenue of redeveloped facilities or those where capacity has been increased in the current or year-earlier period; 3. Revenue generated in the current period by facilities created during the current period or year-earlier period, and the change in revenue of recently acquired facilities by comparison with the previous equivalent period.
EBITDAR	Recurring operating profit before depreciation, amortisation and charges to provisions and before rental expenses.
EBITDA	EBITDAR net of rental expenses on leases of less than one year.
EBITDA pre-IFRS 16	EBITDAR excluding rental expenses on leases of less than one year and excluding lease payments related to leases of more than one year falling within the scope of IFRS 16.
Net debt	Long-term debt + short-term debt - cash and marketable securities (excluding IFRS 16 lease liabilities).
Net recurring operating cash flow	Cash generated by ordinary activities, net of recurring maintenance and IT capital expenditure. Net recurring operating cash flow is the sum of pre-IFRS 16 EBITDA, recurring non-cash items, change in working capital, income tax paid and maintenance and IT capital expenditure.
Net cash flow before financing	Net cash after recurring and non-recurring items, all capital expenditure, interest expense on borrowings, and gains and losses on transactions concerning the asset portfolio. Net cash flow before financing is the sum of net recurring operating cash flow, development capital expenditure, non-recurring items, net income or expense related to the day-to-day management of the asset portfolio and financial expenses.